Clinical trial

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

NCT07553754

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-03-12

PhaseN/A

Study timeline

Study start (actual)2026-03-12Date precision: day

Registry last updated2026-04-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancer (Diagnosis)unresolved

Bone Metastasisunresolved

PSMA PETunresolved

Liquid Biopsyunresolved

Exosomal RNAunresolved

Biomarker Discovery and Validationunresolved

Treament-naiveunresolved

Interventions

Sponsors & collaborators

Xijing Hospitallead sponsor

Air Force Military Medical University, Chinacollaborator

Shaanxi Provincial People's Hospitalcollaborator

Yan'an University Affiliated Hospitalcollaborator

Weinan Central Hospitalcollaborator

The Second Affiliated Hospital of Shaanxi University of Chinese Medicinecollaborator

LanZhou Universitycollaborator

Qinghai Universitycollaborator

General Hospital of Ningxia Medical Universitycollaborator

Mapped research locations

Xi'anShaanxi, China3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07553754 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.